MINNEAPOLIS, June 19, 2014 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced the U.S. market launch of its Gel-Bead embolization spheres for the treatment of hypervascular tumors.
Gel-Bead embolization spheres are precisely sized, bioresorbable beads of gelatin that are absorbed by the body over time, providing physicians with a treatment option for hypervascular tumors in cases when a permanent embolic agent is not desired. Gel-Bead, which received 510(k) clearance from the U.S. Food and Drug Administration in April, will be sold to interventional radiologists who currently embolize hypervascular tumors with microspheres, PVA particles, and gelatin foam slurries.
Help employers find you! Check out all the jobs and post your resume.
